Dr. Mohammed Raja, MD

Dr. Raja practices at Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami.

Dr. Raja's NPI, 1407262033, was assigned on July 2, 2014. Dr. Raja graduated from Gulf Medical University in 2011. Dr. Raja holds Florida license ME143724.

Dr. Raja's primary practice is Sylvester Comprehensive Cancer Center, at 1475 Nw 12th Ave, Miami, FL 33136.

Dr. Raja's primary practice is Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami. The medical group on file is University of Miami Health System. Dmand AI also links Dr. Raja to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Raja practices, 2 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Raja's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Raja is board certified in infectious disease by the American Board of Internal Medicine. Dmand AI has Dr. Raja's licenses on file in 3 states: Florida, Alabama and Illinois.

Dmand AI lists acute skin infection, immune deficiency disease, obesity, pneumonia and UTI among the conditions Dr. Raja treats.

CMS data shows 133 Medicare services from Dr. Raja across 3 procedure codes in 2024, for 79 Medicare patients. Medicare paid $12,464 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 79 Medicare patients who saw Dr. Raja in 2024. The largest group is 65 to 74, with 32 patients. 75% of them have high blood pressure, and 72% have high cholesterol. 41% are also on Medicaid. Their average risk score is 3.82, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Raja's median patient age at 69, with 35% women.

In 2024, Dr. Raja wrote 119 Medicare Part D claims for 19 patients. 61% of them were for generic drugs. CMS names the drug for 70 of them, across 5 drugs with 11 or more claims each, at $173,302 in total drug cost. In 2023, CMS named 55 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Raja for performance year 2024, reported as part of a group. Dr. Raja accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Raja as offering telehealth.

Dmand AI links 24 papers to Dr. Raja, published from 2017 to 2025. 2023 was the busiest year, with 6. The most frequent topics are Transplant Recipients, COVID-19 and Hematopoietic Stem Cell Transplantation. Dr. Raja has published most often in Transpl Infect Dis. Dr. Raja's most frequent co-authors are Yoichiro Natori, MD, Michele I. Morris, MD and Krishna Komanduri, DO.

CMS Open Payments shows 17 general payments to Dr. Raja from 10 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 92% of the total. Penumbra, Inc. paid the most, $533.

Dr. Raja graduated from Gulf Medical University in 2011.

Dr. Raja is in network with 9 carriers, including Elevance, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 5. Check the plan with the practice before a visit.